Complications of Hepatitis B and C Liver Disease

Cost: Free registration.

*Note: this session runs at an earlier time*

This webinar will be presented by:

Alnoor Ramji, MD FRCP(C)
Clinical Associate Professor of Medicine
Gastroenterology and Hepatology, Division of Gastroenterology
University Of British Columbia


Learning Objectives:

  1. Discuss the natural history of persons with hepatitis B or C virus-related liver disease
  2. Describe the implications of therapy on the natural history of hepatitis B or C infection
  3. Identify appropriate modalities for evaluation/screening for complications of hepatitis B and C virus related-liver disease

Presentations will be followed by a discussion where participants will have the opportunity to ask questions and receive real-time responses from presenters.

Please register for the webinar by clicking the following link:

click here.

This event is accredited by the College of Family Physicians of Canada and the British Columbia Chapter for up to 1 Mainpro+ credit.

Please note the session will be recorded and available after the event on the BC-CfE’s website at: education.bccfe.ca/webinars

If you have any questions regarding this event, please contact BC-CfE’s Education and Training team at: education@bccfe.ca. We are looking forward to seeing you there!

Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Attendees of the BC-CfE Learning Series will be able to:
  • Summarize and describe epidemiological, behavioural, virological, and other related research relevant to the management of people living with HIV and other syndemic conditions
  • Describe and demonstrate up-to-date information regarding the care of people living with HIV and syndemic conditions (including viral hepatitis and substance use) particularly in regards to primary care, antiretroviral therapy and other treatments, and comorbid conditions
  • Review new and emerging issues in the context of the management of people living with HIV and other syndemic conditions
  • Identify both clinical and community resources to support the care of people living with HIV and syndemic conditions.
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025